Motivating smokers at outdoor public smoking hotspots to have a quit attempt with a nicotine replacement therapy sample: study protocol for a randomized controlled trial

Yee Tak Derek Cheung, Jessica Pui Kei Leung, Chelsia Ka Ching Cheung, William Ho Cheung Li, Man Ping Wang, Tai Hing Lam, Yee Tak Derek Cheung, Jessica Pui Kei Leung, Chelsia Ka Ching Cheung, William Ho Cheung Li, Man Ping Wang, Tai Hing Lam

Abstract

Background: About half of the daily smokers in Hong Kong have never tried and have no intention to quit smoking. More than one-third (37.9 %) of daily smokers have attempted to quit but failed. Nicotine replacement therapy (NRT) is a safe and effective pharmacotherapy to increase abstinence by reducing withdrawal symptoms during the early stage of smoking abstinence. However, the prevalence of NRT use in Hong Kong is lower than in most developed countries. The proposed study aims to assess the effectiveness of providing free NRT samples to smokers on increasing quit attempts and the quit rate.

Methods: Trained university undergraduate students as ambassadors will invite smokers at outdoor public smoking hotspots to participate in the randomized controlled trial, in which eligible smokers will be randomized to receive a 1-week free NRT sample and medication counselling (intervention) or advice to purchase NRT on their own (control). The primary outcome is self-reported quit attempts (no smoking for at least 24 hours) in the past 30 days at 1-month and 3-month telephone follow-up.

Discussion: The findings will inform the effectiveness of delivering free NRT samples at outdoor public smoking hotspots to increase quit attempts and abstinence. The study will also provide information on smokers' adherence to the NRT sample, side effects and safety issues related to the usage. This will improve the design of a large trial to test the effect of the NRT sample.

Trial registration: ClinicalTrials.gov NCT02491086 . Registered on 7 July 2015.

Keywords: Intervention; Nicotine replacement sample; Smoking cessation; Smoking hotspots.

Figures

Fig. 1
Fig. 1
Flow of outreach interventions. NRT nicotine replacement therapy

References

    1. McGhee S, Ho L, Lapsley H, Chau J, Cheung W, Ho S, Pow M, Lam T, Hedley A. Cost of tobacco-related diseases, including passive smoking, in Hong Kong. Tob Control. 2006;15:125–30.
    1. Koplan JP, An WK, Lam RMK. Hong Kong: a model of successful tobacco control in China. Lancet. 2010;375(9723):1330–1. doi: 10.1016/S0140-6736(10)60398-4.
    1. Census & Statistics Department (Hong Kong SAR Government) Thematic Household Survey, Report No. 53: Pattern of Smoking. Hong Kong: Census & Statistics Department; 2013.
    1. Ashley M, Saunders P, Mullard G, Prasad K, Mariner D, Williamson J, Richter A. Smoking intensity before and after introduction of the public place smoking ban in Scotland. Regul Toxicol Pharmacol. 2011;61(3, Suppl):S60–5.
    1. Kennedy RD, Behm I, Craig L, Thompson ME, Fong GT, Guignard R, Beck F. Outdoor smoking behaviour and support for outdoor smoking restrictions before and after France’s national smoking ban. Eur J Public Health. 2012;22 Suppl 1:29–34.
    1. Chan SSC, Wong DCN, Cheung YTD, Leung DYP, Lau L, Lai V, Lam T-H. A block randomized controlled trial of a brief smoking cessation counselling and advice through short message service on participants who joined the Quit to Win Contest in Hong Kong. Health Educ Res. 2015;30(4):609–21.
    1. Kasza KA, Hyland AJ, Borland R, McNeill AD, Bansal-Travers M, Fix BV, Hammond D, Fong GT, Cummings KM. Effectiveness of stop-smoking medications: findings from the International Tobacco Control (ITC) Four Country Survey. Addiction. 2013;108(1):193–202. doi: 10.1111/j.1360-0443.2012.04009.x.
    1. Lancaster T, Stead L, Silagy C, Sowden A. Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library. BMJ. 2000;321(7257):355–8. doi: 10.1136/bmj.321.7257.355.
    1. Song F, Raftery J, Aveyard P, Hyde C, Barton P, Woolacott N. Cost-effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysis. Med Decis Mak. 2002;22(5 Suppl):S26–37. doi: 10.1177/027298902237708.
    1. Borland R, Li L, Driezen P, Wilson N, Hammond D, Thompson ME, Fong GT, Mons U, Willemsen MC, McNeill A. Cessation assistance reported by smokers in 15 countries participating in the International Tobacco Control (ITC) policy evaluation surveys. Addiction. 2012;107(1):197–205.
    1. Abdullah AS, Hedley AJ, Chan SSC, Lam T-H. A randomized controlled trial of two different lengths of nicotine replacement therapy for smoking cessation. BioMed Res Int. 2013;2013:9.
    1. Barnoya J, Jin L, Hudmon KS, Schootman M. Nicotine replacement therapy, tobacco products, and electronic cigarettes in pharmacies in St. Louis, Missouri. J Am Pharm Assoc. 2015;55(4):405–12. doi: 10.1331/JAPhA.2015.14230.
    1. Fiore MC, Jaén CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, Dorfman SF, Froelicher ES, Goldstein MG, Healton CG, et al. Treating tobacco use and dependence: 2008 update. Rockville: Department of Health and Human Services; 2008.
    1. National Institue for Clinical Excellence . Guidance on the use of nicotine replacement therapy (NRT) and bupropion for smoking cessation. London: NHS National Institue for Clinical Excellence; 2002.
    1. Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot. 1997;12(1):38–48. doi: 10.4278/0890-1171-12.1.38.
    1. West R, Sohal T. ‘Catastrophic’ pathways to smoking cessation: findings from national survey. BMJ. 2006;332(7539):458–60. doi: 10.1136/.
    1. Jiménez-Muro A, Nerín I, Samper P, Marqueta A, Beamonte A, Gargallo P, Oros D, Rodríguez G. A proactive smoking cessation intervention in postpartum women. Midwifery. 2013;29(3):240–5.
    1. Carpenter MJ, Hughes JR, Gray KM, Wahlquist AE, Saladin ME, Alberg AJ. Nicotine therapy sampling to induce quit attempts among smokers unmotivated to quit: a randomized clinical trial. Arch Intern Med. 2011;171(21):1901–7. doi: 10.1001/archinternmed.2011.492.
    1. Jardin BF, Cropsey KL, Wahlquist AE, Gray KM, Silvestri GA, Cummings KM, Carpenter MJ. Evaluating the effect of access to free medication to quit smoking: a clinical trial testing the role of motivation. Nicotine Tob Res. 2014;16:992-999.
    1. Larabie LC. To what extent do smokers plan quit attempts? Tob Control. 2005;14(6):425–8. doi: 10.1136/tc.2005.013615.
    1. Ferguson SG, Shiffman S, Gitchell JG, Sembower MA, West R. Unplanned quit attempts—results from a US sample of smokers and ex-smokers. Nicotine Tob Res. 2009;11:827-832.
    1. Murray RL, Lewis SA, Coleman T, Britton J, McNeill A. Unplanned attempts to quit smoking: missed opportunities for health promotion? Addiction. 2009;104(11):1901–9. doi: 10.1111/j.1360-0443.2009.02647.x.
    1. Shiffman S, Ferguson SG, Rohay J, Gitchell JG. Perceived safety and efficacy of nicotine replacement therapies among US smokers and ex-smokers: relationship with use and compliance. Addiction. 2008;103(8):1371–8. doi: 10.1111/j.1360-0443.2008.02268.x.
    1. Ferguson SG, Gitchell JG, Shiffman S, Sembower MA, Rohay JM, Allen J. Providing accurate safety information may increase a smoker’s willingness to use nicotine replacement therapy as part of a quit attempt. Addict Behav. 2011;36(7):713–6. doi: 10.1016/j.addbeh.2011.02.002.
    1. Vogt F, Hall S, Marteau TM. Understanding why smokers do not want to use nicotine dependence medications to stop smoking: qualitative and quantitative studies. Nicotine Tob Res. 2008;10(8):1405–13. doi: 10.1080/14622200802239280.
    1. Lindson-Hawley N, Aveyard P, Hughes JR. Reduction versus abrupt cessation in smokers who want to quit. Cochrane Database Syst Rev. 2012;2012:11.
    1. Asfar T, Ebbert JO, Klesges RC, Relyea GE. Do smoking reduction interventions promote cessation in smokers not ready to quit? Addict Behav. 2011;36(7):764–8. doi: 10.1016/j.addbeh.2011.02.003.
    1. The Tobacco Use and Dependence Clinical Practice Guideline Panel (Staff and Consortium Representatives) A clinical practice guideline for treating tobacco use and dependence. A US public health service report. JAMA. 2000;283:3244–54. doi: 10.1001/jama.283.24.3244.
    1. Medline Plus. Nicotine replacement therapy. In: Nicotine Replacement Therapy: MedlinePlus Medical Encyclopedia. Bethesda, Maryland: US National Library of Medicine, National Insititutes of Health; 2009.
    1. World Health Organization . Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.
    1. Chan SSC, Leung DYP, Abdullah ASM, Wong VT, Hedley AJ, Lam T-H. A randomized controlled trial of a smoking reduction plus nicotine replacement therapy intervention for smokers not willing to quit smoking. Addiction. 2011;106(6):1155–63. doi: 10.1111/j.1360-0443.2011.03363.x.
    1. Lam T-H, Abdullah ASM, Chan SSC, Hedley AJ, Hong Kong Council on Smoking, Health Smoking Cessation Health Centre Steering Group Adherence to nicotine replacement therapy versus quitting smoking among Chinese smokers: a preliminary investigation. Psychopharmacology. 2005;177(4):400–8. doi: 10.1007/s00213-004-1971-y.
    1. Cooke F, Bullen C, Whittaker R, McRobbie H, Chen M-H, Walker N. Diagnostic accuracy of nicalert cotinine test strips in saliva for verifying smoking status. Nicotine Tob Res. 2008;10(4):607–12. doi: 10.1080/14622200801978680.
    1. Javors MA, Hatch JP, Lamb RJ. Cut-off levels for breath carbon monoxide as a marker for cigarette smoking. Addiction. 2005;100(2):159–67. doi: 10.1111/j.1360-0443.2004.00957.x.
    1. Doig GS, Simpson F. Randomization and allocation concealment: a practical guide for researchers. J Crit Care. 2005;20(2):187–91. doi: 10.1016/j.jcrc.2005.04.005.
    1. Chan A-W, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin JA, Dickersin K, Hróbjartsson A, Schulz KF, Parulekar WR. et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586.
    1. Hong Kong Council on Smoking and Health . June 2013, COSH Report No. 16—‘Quit to Win 2010’ and smoking cessation. Hong Kong: Hong Kong Council on Smoking Health; 2014.
    1. Fu SS, van Ryn M, Sherman SE, et al. Proactive tobacco treatment and population-level cessation: a pragmatic randomized clinical trial. JAMA Intern Med. 2014;174(5):671–7. doi: 10.1001/jamainternmed.2014.177.
    1. Tzelepis F, Paul CL, Wiggers J, Walsh RA, Knight J, Duncan SL, Lecathelinais C, Girgis A, Daly J. A randomised controlled trial of proactive telephone counselling on cold-called smokers’ cessation rates. Tob Control. 2011;20(1):40–6.
    1. Yang J, Hammond D, Driezen P, Fong GT, Jiang Y. Health knowledge and perception of risks among Chinese smokers and non-smokers: findings from the Wave 1 ITC China Survey. Tob Control. 2010;19(Suppl 2):i18–23. doi: 10.1136/tc.2009.029710.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren